Marginum
Kuopio, FI · 2 known investors
Find your way into Marginum
Sign up to see every warm intro you have to Marginum
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Marginum team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Marginum develops a fluorescence-based optical tissue monitoring technology that detects tumour cells from surgical suction waste in near real-time to help surgeons perform more accurate resections during cancer surgery. The system integrates into existing surgical workflows and is aimed at oncological surgery to reduce reoperations and improve patient outcomes.
Founders & leadership
SL

Samu LehtonenCEO & Co-FounderDr. Samu Lehtonen is a physician and researcher who conducted microsurgical technology research at the Microsurgery Centre of Eastern Finland before co-founding Marginum, where he serves as CEO and has published work in peer-reviewed journals on the company's optical tissue monitoring technology.
Investors · 2
Frequently asked questions
- What does Marginum do?
- Marginum develops a fluorescence-based optical tissue monitoring technology that detects tumour cells from surgical suction waste in near real-time to help surgeons perform more accurate resections during cancer surgery. The system integrates into existing surgical workflows and is aimed at oncological surgery to reduce reoperations and improve patient outcomes.
- Who founded Marginum?
- Marginum was founded by Samu Lehtonen.
- Who are Marginum's investors?
- Marginum's investors include Nostetta Ventures, Tane Fund.
- Where is Marginum headquartered?
- Marginum is headquartered in Kuopio, FI.

